# Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke

> **NCT05728333** · PHASE2,PHASE3 · RECRUITING · sponsor: **Xinqiao Hospital of Chongqing** · enrollment: 800 (estimated)

## Conditions studied

- Stroke, Acute Ischemic

## Interventions

- **DRUG:** Tirofiban
- **DRUG:** Alteplase

## Key facts

- **NCT ID:** NCT05728333
- **Lead sponsor:** Xinqiao Hospital of Chongqing
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-28
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-07-31
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2025-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05728333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05728333, "Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05728333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*